CC-92480 (BMS-986348)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CC-92480 (BMS-986348), covering 2025-09-05 to 2025-09-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]